US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kairos Pharma, Ltd.

0.6400

+0.00891.41%

Post-market: 0.6160-0.0240-3.75%17:12 EDT

Volume:174.41K

Turnover:110.35K

Market Cap:13.33M

PE:-2.09

High:0.6500

Open:0.6310

Low:0.6121

Close:0.6311

52wk High:2.11

52wk Low:0.4000

Shares:20.82M

Float Shares:1.55M

Volume Ratio:0.66

T/O Rate:11.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3056

EPS(LYR):-0.2292

ROE:-92.07%

ROA:-53.59%

PB:1.74

PE(LYR):-2.79

Loading ...

Overview Company News Filings

Kairos Pharma to Present at ESMO Congress 2025

Kairos Pharma Announces Positive Interim Results from Phase 2 Trial of ENV105 in Advanced Prostate Cancer, Set to Present at ESMO 2025

Kairos Pharma to Present Positive Safety and Efficacy Data From Phase 2 Prostate Cancer Trial at Esmo 2025

THOMSON REUTERS

Kairos Pharma Is Maintained at Buy by D. Boral Capital

Kairos Pharma Reports Positive Phase 2 Trial Results

Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of Env105 in Advanced Prostate Cancer With Median Progression Free Survival of Over One Year

THOMSON REUTERS

Kairos Pharma’s Promising Developments and Positive Trial Data Reinforce Buy Recommendation

Kapa Gold Inc. Secures $710,520 Through Warrant Exercise to Bolster Operations

Kairos Pharma to Host KOL Event on Phase 2 Trial

Kairos Pharma to Host KOL Event Discussing Promising Interim Efficacy Results of ENV105 in Advanced Prostate Cancer Trial

Kairos Pharma Announces Virtual Kol Event to Provide Perspectives on Env105 Interim Efficacy Results in Advanced Prostate Cancer

THOMSON REUTERS

Xinhua Silk Road: E. China's Weihai embraces new certification center for auto parts export to ROK

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/KAPA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KAPA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAPA\",,,,,undefined,":{"symbol":"KAPA","market":"US","secType":"STK","nameCN":"Kairos Pharma, Ltd.","latestPrice":0.64,"timestamp":1773172800000,"preClose":0.6311,"halted":0,"volume":174412,"hourTrading":{"tag":"盘后","latestPrice":0.616,"preClose":0.64,"latestTime":"17:12 EDT","volume":137,"amount":84.392,"timestamp":1773177173616,"change":-0.024,"changeRate":-0.0375,"amplitude":0},"delay":0,"changeRate":0.014102360957059133,"floatShares":1550000,"shares":20821353,"eps":-0.30563,"marketStatus":"Post-Mkt","change":0.0089,"latestTime":"03-10 17:24:35 EDT","open":0.631,"high":0.65,"low":0.612101,"amount":110354.43852888,"amplitude":0.060052,"askPrice":0.6947,"askSize":100,"bidPrice":0.62,"bidSize":15,"shortable":3,"etf":0,"ttmEps":-0.30563,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1773187200000},"marketStatusCode":4,"adr":0,"listingDate":1717992000000,"exchange":"AMEX","adjPreClose":0.6311,"preHourTrading":{"tag":"盘前","latestPrice":0.6311,"preClose":0.6311,"latestTime":"09:26 EDT","volume":1579,"amount":973.1249732599999,"timestamp":1773149213145,"change":0,"changeRate":0,"amplitude":0.044842},"postHourTrading":{"tag":"盘后","latestPrice":0.616,"preClose":0.64,"latestTime":"17:12 EDT","volume":137,"amount":84.392,"timestamp":1773177173616,"change":-0.024,"changeRate":-0.0375,"amplitude":0},"volumeRatio":0.65852},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAPA\",,,,,undefined,":{"symbol":"KAPA","floatShares":1550000,"roa":"-53.59%","roe":"-92.07%","lyrEps":-0.229208,"volumeRatio":0.65852,"shares":20821353,"dividePrice":0,"high":0.65,"amplitude":0.060052,"preClose":0.6311,"low":0.612101,"week52Low":0.4,"pbRate":"1.74","week52High":2.11,"institutionHeld":0,"latestPrice":0.64,"committee":-0.73913,"eps":-0.30563,"divideRate":0,"volume":174412,"delay":0,"ttmEps":-0.30563,"open":0.631,"prevYearClose":0.71,"prevWeekClose":0.6299,"prevMonthClose":0.6055,"prevQuarterClose":0.71,"fiveDayClose":0.6242,"twentyDayClose":0.64,"sixtyDayClose":0.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KAPA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KAPA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KAPA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KAPA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KAPA","date":"2026-03-09","current":-2.064915,"percent":0.934959,"low":-25.607053,"twenty":-7.414671,"median":-5.019718,"eighty":-3.084691,"high":-2.140651,"avg":-5.53777,"sd":2.928247,"marketCap":13115370},"quantilePoints":[{"date":"2024-09-13","current":-25.607053,"twenty":-25.607053,"median":-25.607053,"eighty":-25.607053,"marketCap":51367748},{"date":"2024-09-20","current":-14.59602,"twenty":-25.607053,"median":-16.196461,"eighty":-14.724055,"marketCap":29279616},{"date":"2024-09-27","current":-10.594918,"twenty":-16.644584,"median":-14.59602,"eighty":-12.803526,"marketCap":21253405},{"date":"2024-10-04","current":-8.706398,"twenty":-15.748337,"median":-12.835535,"eighty":-9.858715,"marketCap":17465034},{"date":"2024-10-11","current":-9.410592,"twenty":-14.724055,"median":-10.594918,"eighty":-8.706398,"marketCap":18877647},{"date":"2024-10-18","current":-9.410592,"twenty":-14.59602,"median":-9.890724,"eighty":-9.026486,"marketCap":18877647},{"date":"2024-10-25","current":-9.602645,"twenty":-14.019861,"median":-9.73068,"eighty":-9.026486,"marketCap":19262905},{"date":"2024-10-31","current":-8.64238,"twenty":-13.098007,"median":-9.602645,"eighty":-8.947104,"marketCap":17336614},{"date":"2024-11-08","current":-8.770415,"twenty":-12.81633,"median":-9.464686,"eighty":-8.64238,"marketCap":17593453},{"date":"2024-11-15","current":-13.158824,"twenty":-13.152678,"median":-9.474609,"eighty":-8.64238,"marketCap":26396601},{"date":"2024-11-22","current":-7.030345,"twenty":-12.924264,"median":-9.410592,"eighty":-8.578362,"marketCap":19270177},{"date":"2024-11-29","current":-7.217821,"twenty":-12.829133,"median":-9.282556,"eighty":-8.469532,"marketCap":19784048},{"date":"2024-12-06","current":-6.608525,"twenty":-12.265778,"median":-9.026486,"eighty":-7.967725,"marketCap":18113966},{"date":"2024-12-13","current":-8.061463,"twenty":-11.119862,"median":-8.738406,"eighty":-7.667763,"marketCap":22096470},{"date":"2024-12-20","current":-7.920856,"twenty":-10.268428,"median":-8.706398,"eighty":-7.780249,"marketCap":21711066},{"date":"2024-12-27","current":-7.827118,"twenty":-9.999554,"median":-8.64238,"eighty":-7.780249,"marketCap":21454130},{"date":"2025-01-03","current":-7.170953,"twenty":-9.909929,"median":-8.578362,"eighty":-7.46154,"marketCap":19655581},{"date":"2025-01-10","current":-4.827504,"twenty":-9.858715,"median":-8.578362,"eighty":-7.311559,"marketCap":13232188},{"date":"2025-01-17","current":-8.295808,"twenty":-9.858715,"median":-8.530349,"eighty":-7.261949,"marketCap":22738809},{"date":"2025-01-24","current":-7.311559,"twenty":-9.756287,"median":-8.373067,"eighty":-7.264142,"marketCap":20040984},{"date":"2025-01-31","current":-6.936607,"twenty":-9.73068,"median":-8.108332,"eighty":-7.170953,"marketCap":19013241},{"date":"2025-02-07","current":-6.749132,"twenty":-9.628252,"median":-8.036517,"eighty":-7.161579,"marketCap":18499370},{"date":"2025-02-14","current":-6.796001,"twenty":-9.602645,"median":-7.967725,"eighty":-7.030345,"marketCap":18627838},{"date":"2025-02-21","current":-6.233573,"twenty":-9.526207,"median":-7.967725,"eighty":-7.030345,"marketCap":17086224},{"date":"2025-02-28","current":-5.671145,"twenty":-9.474865,"median":-7.897422,"eighty":-6.869431,"marketCap":15544609},{"date":"2025-03-07","current":-5.198227,"twenty":-9.462702,"median":-7.803684,"eighty":-6.730384,"marketCap":14248340},{"date":"2025-03-14","current":-4.773372,"twenty":-9.428261,"median":-7.780249,"eighty":-6.44917,"marketCap":13083812},{"date":"2025-03-21","current":-4.898329,"twenty":-9.410592,"median":-7.639642,"eighty":-6.289816,"marketCap":13426320},{"date":"2025-03-28","current":-4.848346,"twenty":-9.33377,"median":-7.452166,"eighty":-6.092966,"marketCap":13289317},{"date":"2025-04-04","current":-4.698397,"twenty":-9.282556,"median":-7.358428,"eighty":-5.577408,"marketCap":12878307},{"date":"2025-04-11","current":-4.948312,"twenty":-9.244146,"median":-7.311559,"eighty":-5.297393,"marketCap":13563323},{"date":"2025-04-17","current":-4.775903,"twenty":-9.141718,"median":-7.263319,"eighty":-5.121191,"marketCap":12431676},{"date":"2025-04-25","current":-5.470376,"twenty":-9.018804,"median":-7.217821,"eighty":-5.172643,"marketCap":14239390},{"date":"2025-05-02","current":-5.034285,"twenty":-8.912535,"median":-7.170953,"eighty":-5.172643,"marketCap":13104245},{"date":"2025-05-09","current":-4.841892,"twenty":-8.744808,"median":-7.124084,"eighty":-5.140524,"marketCap":12603446},{"date":"2025-05-16","current":-2.898471,"twenty":-8.706398,"median":-7.030345,"eighty":-5.053706,"marketCap":10266383},{"date":"2025-05-23","current":-2.643971,"twenty":-8.706398,"median":-7.030345,"eighty":-4.968305,"marketCap":9364944},{"date":"2025-05-30","current":-2.626341,"twenty":-8.693594,"median":-6.936607,"eighty":-4.902727,"marketCap":9302501},{"date":"2025-06-06","current":-2.390394,"twenty":-8.64238,"median":-6.865004,"eighty":-4.843183,"marketCap":8466776},{"date":"2025-06-13","current":-2.711492,"twenty":-8.629576,"median":-6.796001,"eighty":-4.780395,"marketCap":9604104},{"date":"2025-06-20","current":-2.911286,"twenty":-8.578362,"median":-6.702263,"eighty":-4.758377,"marketCap":10311775},{"date":"2025-06-27","current":-3.282332,"twenty":-8.578362,"median":-6.467918,"eighty":-4.698397,"marketCap":11626021},{"date":"2025-07-03","current":-3.096809,"twenty":-8.578362,"median":-6.421049,"eighty":-4.598431,"marketCap":10968898},{"date":"2025-07-11","current":-3.382229,"twenty":-8.578362,"median":-6.327311,"eighty":-4.315248,"marketCap":11979856},{"date":"2025-07-18","current":-4.852143,"twenty":-8.578362,"median":-6.210138,"eighty":-4.078861,"marketCap":17186292},{"date":"2025-07-25","current":-4.424013,"twenty":-8.501541,"median":-6.156578,"eighty":-4.315248,"marketCap":15669854},{"date":"2025-08-01","current":-4.281779,"twenty":-8.456729,"median":-5.830571,"eighty":-4.144691,"marketCap":15166060},{"date":"2025-08-08","current":-4.566723,"twenty":-8.326712,"median":-5.698056,"eighty":-4.256377,"marketCap":16175333},{"date":"2025-08-15","current":-5.460044,"twenty":-8.265781,"median":-5.577408,"eighty":-4.144691,"marketCap":25722268},{"date":"2025-08-22","current":-5.151816,"twenty":-8.175816,"median":-5.56016,"eighty":-4.256377,"marketCap":24270205},{"date":"2025-08-29","current":-5.548109,"twenty":-8.117706,"median":-5.504045,"eighty":-4.350727,"marketCap":26137143},{"date":"2025-09-05","current":-6.825055,"twenty":-8.080211,"median":-5.554134,"eighty":-4.371339,"marketCap":32152835},{"date":"2025-09-12","current":-7.925871,"twenty":-8.146034,"median":-5.577408,"eighty":-4.403843,"marketCap":37338777},{"date":"2025-09-19","current":-5.90037,"twenty":-8.123413,"median":-5.684601,"eighty":-4.424013,"marketCap":27796645},{"date":"2025-09-26","current":-5.019718,"twenty":-8.080211,"median":-5.577408,"eighty":-4.452555,"marketCap":23647892},{"date":"2025-10-03","current":-5.063751,"twenty":-8.031527,"median":-5.554134,"eighty":-4.485854,"marketCap":23855329},{"date":"2025-10-10","current":-5.812305,"twenty":-7.985263,"median":-5.56016,"eighty":-4.525921,"marketCap":27381769},{"date":"2025-10-17","current":-5.151816,"twenty":-7.967725,"median":-5.531688,"eighty":-4.55855,"marketCap":24270205},{"date":"2025-10-24","current":-4.799555,"twenty":-7.967725,"median":-5.492822,"eighty":-4.58125,"marketCap":22610703},{"date":"2025-10-31","current":-5.019718,"twenty":-7.967725,"median":-5.46521,"eighty":-4.595432,"marketCap":23647892},{"date":"2025-11-07","current":-3.830837,"twenty":-7.967725,"median":-5.399832,"eighty":-4.525921,"marketCap":18047075},{"date":"2025-11-14","current":-3.48298,"twenty":-7.942613,"median":-5.371979,"eighty":-4.424013,"marketCap":16408318},{"date":"2025-11-21","current":-2.82458,"twenty":-7.922862,"median":-5.327946,"eighty":-4.230974,"marketCap":14298023},{"date":"2025-11-28","current":-3.42923,"twenty":-7.902108,"median":-5.296194,"eighty":-4.097795,"marketCap":17358761},{"date":"2025-12-05","current":-3.740193,"twenty":-7.855239,"median":-5.283914,"eighty":-3.903739,"marketCap":18932856},{"date":"2025-12-12","current":-3.331745,"twenty":-7.817744,"median":-5.203591,"eighty":-3.780288,"marketCap":16865295},{"date":"2025-12-19","current":-3.187781,"twenty":-7.79431,"median":-5.197038,"eighty":-3.655562,"marketCap":16136548},{"date":"2025-12-26","current":-3.052866,"twenty":-7.780249,"median":-5.190491,"eighty":-3.531486,"marketCap":15453608},{"date":"2026-01-02","current":-2.920419,"twenty":-7.780249,"median":-5.153702,"eighty":-3.48298,"marketCap":14783160},{"date":"2026-01-09","current":-3.989868,"twenty":-7.780249,"median":-5.151816,"eighty":-3.42923,"marketCap":20196712},{"date":"2026-01-16","current":-3.660807,"twenty":-7.780249,"median":-5.14469,"eighty":-3.42923,"marketCap":18531004},{"date":"2026-01-23","current":-3.208347,"twenty":-7.755842,"median":-5.119133,"eighty":-3.42923,"marketCap":16240655},{"date":"2026-01-30","current":-2.734499,"twenty":-7.661662,"median":-5.098261,"eighty":-3.381278,"marketCap":13842035},{"date":"2026-02-06","current":-2.426827,"twenty":-7.586816,"median":-5.063751,"eighty":-3.364521,"marketCap":12284598},{"date":"2026-02-13","current":-2.442869,"twenty":-7.51395,"median":-5.063751,"eighty":-3.27767,"marketCap":12365801},{"date":"2026-02-20","current":-2.303429,"twenty":-7.470914,"median":-5.048278,"eighty":-3.204892,"marketCap":11659957},{"date":"2026-02-27","current":-2.271757,"twenty":-7.452166,"median":-5.027001,"eighty":-3.156747,"marketCap":11499633},{"date":"2026-03-06","current":-2.698302,"twenty":-7.424045,"median":-5.019718,"eighty":-3.093003,"marketCap":13658807},{"date":"2026-03-09","current":-2.590946,"twenty":-7.414671,"median":-5.019718,"eighty":-3.084691,"marketCap":13115370}],"updateTime":1773140650713},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KAPA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2573950582","title":"Kairos Pharma to Present at ESMO Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2573950582","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573950582?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:28","pubTimestamp":1759840131,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. ( ($KAPA) ) has provided an announcement. On October 7, 2025, Kairos Pharma announced its selection to present at the European ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-to-present-at-esmo-congress-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-to-present-at-esmo-congress-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAPA","KAIR","BK4139"],"gpt_icon":0},{"id":"2573952440","title":"Kairos Pharma Announces Positive Interim Results from Phase 2 Trial of ENV105 in Advanced Prostate Cancer, Set to Present at ESMO 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2573952440","media":"Reuters","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573952440?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:00","pubTimestamp":1759838431,"startTime":"0","endTime":"0","summary":"Kairos Pharma Announces Positive Interim Results from Phase 2 Trial of ENV105 in Advanced Prostate Cancer, Set to Present at ESMO 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kairos Pharma Ltd. published the original content used to generate this news brief via Business Wire  on October 07, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDL71qk7t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2573952104","title":"Kairos Pharma to Present Positive Safety and Efficacy Data From Phase 2 Prostate Cancer Trial at Esmo 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2573952104","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573952104?lang=en_us&edition=fundamental","pubTime":"2025-10-07 20:00","pubTimestamp":1759838400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nTUABYQWSW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KAPA"],"gpt_icon":0},{"id":"2568243257","title":"Kairos Pharma Is Maintained at Buy by D. Boral Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2568243257","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568243257?lang=en_us&edition=fundamental","pubTime":"2025-09-19 19:26","pubTimestamp":1758281160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KAPA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 19, 2025 07:26 ET (11:26 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","KAIR"],"gpt_icon":0},{"id":"2568547732","title":"Kairos Pharma Reports Positive Phase 2 Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2568547732","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568547732?lang=en_us&edition=fundamental","pubTime":"2025-09-18 20:30","pubTimestamp":1758198652,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. ( ($KAPA) ) has issued an update. On September 18, 2025, Kairos Pharma announced positive interim efficacy data from its Phase ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-reports-positive-phase-2-trial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-reports-positive-phase-2-trial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAPA","KAIR","BK4139"],"gpt_icon":0},{"id":"2568184474","title":"Kairos Pharma Announces Positive Interim Efficacy Analysis of Phase 2 Trial of Env105 in Advanced Prostate Cancer With Median Progression Free Survival of Over One Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2568184474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568184474?lang=en_us&edition=fundamental","pubTime":"2025-09-18 20:00","pubTimestamp":1758196841,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250918:nFWN3V515Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2568416246","title":"Kairos Pharma’s Promising Developments and Positive Trial Data Reinforce Buy Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2568416246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568416246?lang=en_us&edition=fundamental","pubTime":"2025-09-18 02:15","pubTimestamp":1758132914,"startTime":"0","endTime":"0","summary":"Analyst Jason McCarthy of Maxim Group reiterated a Buy rating on Kairos Pharma, Ltd., retaining the price target of $4.00. Jason McCarthy has given...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kairos-pharmas-promising-developments-and-positive-trial-data-reinforce-buy-recommendation-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kairos-pharmas-promising-developments-and-positive-trial-data-reinforce-buy-recommendation-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAIR","KAPA","BK4139"],"gpt_icon":0},{"id":"2568482357","title":"Kapa Gold Inc. Secures $710,520 Through Warrant Exercise to Bolster Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2568482357","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568482357?lang=en_us&edition=fundamental","pubTime":"2025-09-17 00:41","pubTimestamp":1758040896,"startTime":"0","endTime":"0","summary":"KAPA Gold Inc ( ($TSE:KAPA) ) has provided an update. Kapa Gold Inc. has announced the successful exercise of 3,552,600 warrants at a price of $0.2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kapa-gold-inc-secures-710520-through-warrant-exercise-to-bolster-operations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kapa-gold-inc-secures-710520-through-warrant-exercise-to-bolster-operations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SGUmain","518880","GDX","159934","GCmain","IAU","KAPA","NUGT","SGCmain","MGCmain","1OZmain","BK4139","DUST"],"gpt_icon":0},{"id":"2566995604","title":"Kairos Pharma to Host KOL Event on Phase 2 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2566995604","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566995604?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:31","pubTimestamp":1757593875,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. ( ($KAPA) ) has shared an announcement. On September 11, 2025, Kairos Pharma announced it will host a virtual Key Opinion Leade...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-to-host-kol-event-on-phase-2-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-to-host-kol-event-on-phase-2-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4181","KAIR","BK4585","BK4588","BK4139","HST","KOL","BK4218","KAPA"],"gpt_icon":0},{"id":"2566998286","title":"Kairos Pharma to Host KOL Event Discussing Promising Interim Efficacy Results of ENV105 in Advanced Prostate Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2566998286","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566998286?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:00","pubTimestamp":1757592032,"startTime":"0","endTime":"0","summary":"Kairos Pharma Ltd. has announced a forthcoming virtual Key Opinion Leader  event to discuss the interim efficacy results of its Phase 2 trial for ENV105, a first-in-class CD105 antagonist, in treating advanced prostate cancer. The event is scheduled for September 18th and will feature perspectives from principal investigators involved in the trial. The interim safety analysis reported in July indicated that ENV105 was well tolerated when combined with standard hormone therapy, apalutamide, in the initial 10 patients, with no dose-limiting toxicities or unexpected adverse events observed. Participants can register to receive access to the webcast, where experts including Dr. Neil Bhowmick, Dr. Umang Swami, Dr. Richard Lee, and Dr. Edwin Posadas will provide insights on the trial results and the potential role of ENV105 in addressing cancer drug resistance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nNDL9njcbp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2566113998","title":"Kairos Pharma Announces Virtual Kol Event to Provide Perspectives on Env105 Interim Efficacy Results in Advanced Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2566113998","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566113998?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:00","pubTimestamp":1757592001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250911:nTUA4QG6TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KAPA"],"gpt_icon":0},{"id":"2566866152","title":"Xinhua Silk Road: E. China's Weihai embraces new certification center for auto parts export to ROK","url":"https://stock-news.laohu8.com/highlight/detail?id=2566866152","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566866152?lang=en_us&edition=fundamental","pubTime":"2025-09-09 14:46","pubTimestamp":1757400360,"startTime":"0","endTime":"0","summary":"BEIJING, Sept. 9, 2025 /PRNewswire/ -- Weihai, a coastal city sitting in east China's Shandong Province, welcomed a new \"dweller\" in its integrated free trade zone, the certification center for auto parts export to the Republic of Korea  recently.For years, Weihai Integrated Free Trade Zone has leveraged its forefront role in boosting Sino-ROK cooperation and cultivated a batch of competitive manufacturers in semiconductor, electronics, and food processing fields.In mid-August, Weihai Integrated Free Trade Zone, Korea Testing Certification  and Korea Automobile Parts Association  signed a tripartite agreement over the certification center.According to them, the certification center, upon completion, will take advantage of related favorable policies in the free trade zone to forge a global certification service regime for auto parts and other related daily necessities and home appliances.Apart from this, an integrated operating system that includes certification, storage and export will","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/xinhua-silk-road-e-chinas-weihai-embraces-new-certification-center-for-auto-parts-export-to-rok-302550317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739343.SGD","LU0390134368.USD","LU0289961442.SGD","LU0511384066.AUD","BK4588","KAPA","BK4580","LU2264538146.SGD","LU0154245673.USD","LU0472753341.HKD","LU0689626769.HKD","BK4139","LU1064131342.USD","ROK","LU0154245756.USD","BK4585","LU1894683264.USD","LU0069063385.USD","LU0124676726.USD","LU1894683348.USD","LU1988902786.USD","LU0057025933.USD","BK4096"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":32,"code":"91000000","status":"200"}]}}